Our website is made possible by displaying non-intrusive online advertisements to our visitors.
Please consider supporting us by disabling or pausing your ad blocker.
possible censor by top management as not to attract much attention. The plan to privatize GenM with low valuation still stand. 1 more month to go before the restriction of the 6 months period is lifted for privatization offer again.
most of the negatives have been addressed such as penalty by the Las Vegas Authority and also winning the court case with its Bahmas partner and successfully obtained the NY license. instead of rebound, it cont to dive down until 2.20 price which is around the margin call price.
yet to revert formally to UK MHRA even after almost 7 months. there could be complications in the data gathering and have exceeded the 6 months time frame.